Stockscreener 앱 받기
44.72
1.57%
0.69
시간 외 거래:
45.22
0.50
+1.12%
전일 마감가:
$44.03
열려 있는:
$44.7
하루 거래량:
2.33M
Relative Volume:
1.91
시가총액:
$3.58B
수익:
-
순이익/손실:
$-269.44M
주가수익비율:
-11.93
EPS:
-3.75
순현금흐름:
$-262.63M
1주 성능:
-4.30%
1개월 성능:
-9.77%
6개월 성능:
-0.91%
1년 성능:
+69.72%
1일 변동 폭
$44.04
$45.37
1주일 범위
$43.08
$47.67
52주 변동 폭
$21.34
$58.40
Akero Therapeutics Inc Stock (AKRO) Company Profile
명칭
Akero Therapeutics Inc
전화
650-487-6488
주소
601 GATEWAY BOULEVARD, SUITE 350, SOUTH SAN FRANCISCO, CA
AKRO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AKRO
Akero Therapeutics Inc
|
44.72 | 3.52B | 0 | -269.44M | -262.63M | -3.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Akero Therapeutics Inc Stock (AKRO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-04 | 재개 | H.C. Wainwright | Buy |
| 2025-08-04 | 개시 | TD Cowen | Buy |
| 2025-01-30 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2025-01-27 | 재확인 | H.C. Wainwright | Buy |
| 2024-11-18 | 개시 | Citigroup | Buy |
| 2024-04-22 | 재개 | BofA Securities | Neutral |
| 2023-09-19 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-08-28 | 개시 | UBS | Buy |
| 2023-01-27 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-09-14 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2021-10-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-09-10 | 개시 | BofA Securities | Buy |
| 2021-02-26 | 개시 | Guggenheim | Buy |
| 2020-09-10 | 개시 | Morgan Stanley | Overweight |
| 2020-07-20 | 재확인 | H.C. Wainwright | Buy |
| 2020-07-07 | 개시 | Chardan Capital Markets | Buy |
| 2020-07-01 | 재확인 | H.C. Wainwright | Buy |
| 2020-03-02 | 개시 | H.C. Wainwright | Buy |
| 2020-02-10 | 개시 | Canaccord Genuity | Buy |
| 2019-07-15 | 개시 | Evercore ISI | Outperform |
| 2019-07-15 | 개시 | JP Morgan | Overweight |
| 2019-07-15 | 개시 | Jefferies | Buy |
| 2019-07-15 | 개시 | ROTH Capital | Buy |
모두보기
Akero Therapeutics Inc 주식(AKRO)의 최신 뉴스
Candlestick signals on Akero Therapeutics Inc. stock todayMarket Rally & Community Verified Watchlist Alerts - Newser
Risk adjusted return profile for Akero Therapeutics Inc. analyzedPortfolio Performance Report & AI Based Trade Execution Alerts - Newser
Analysts Set Akero Therapeutics, Inc. (NASDAQ:AKRO) Target Price at $81.57 - MarketBeat
Akero Therapeutics (NASDAQ:AKRO) Now Covered by Analysts at HC Wainwright - MarketBeat
440,000 Shares in Akero Therapeutics, Inc. $AKRO Acquired by EcoR1 Capital LLC - MarketBeat
What hedge funds are buying Akero Therapeutics Inc.2025 Market Trends & High Return Stock Watch Alerts - 강소기업뉴스
How cyclical is Akero Therapeutics Inc.’s revenue streamWeekly Market Summary & Real-Time Stock Entry Alerts - خودرو بانک
Is Akero Therapeutics Inc. in a consolidation phaseM&A Rumor & Free High Accuracy Swing Entry Alerts - خودرو بانک
HighTower Advisors LLC Acquires Shares of 7,221 Akero Therapeutics, Inc. $AKRO - MarketBeat
Will Akero Therapeutics Inc. benefit from government policyJuly 2025 Trends & Community Trade Idea Sharing - خودرو بانک
Will Akero Therapeutics Inc. price bounce be sustainableShort Setup & Fast Gain Stock Trading Tips - Newser
Propel Bio Management LLC Sells 114,845 Shares of Akero Therapeutics, Inc. $AKRO - MarketBeat
Northern Trust Corp Buys 36,412 Shares of Akero Therapeutics, Inc. $AKRO - MarketBeat
AQST Stock Up as FDA Skips Advisory Meeting to Discuss Anaphylm NDA - sharewise.com
Can Akero Therapeutics Inc. deliver alphaJuly 2025 Short Interest & Accurate Intraday Trading Signals - خودرو بانک
Cubist Systematic Strategies LLC Raises Stock Holdings in Akero Therapeutics, Inc. $AKRO - MarketBeat
Allostery Investments LP Invests $729,000 in Akero Therapeutics, Inc. $AKRO - MarketBeat
Is Akero Therapeutics Inc. a strong growth stockQuarterly Portfolio Review & Accurate Entry/Exit Alerts - خودرو بانک
How to interpret RSI for Akero Therapeutics Inc. stockQuarterly Portfolio Report & Growth Focused Entry Reports - Newser
Akero Therapeutics, Inc. $AKRO Shares Purchased by Long Focus Capital Management LLC - MarketBeat
Key resistance and support levels for Akero Therapeutics Inc.2025 Buyback Activity & Expert Approved Trade Ideas - Newser
Is Akero Therapeutics Inc. forming a reversal patternMarket Activity Recap & Free Fast Gain Swing Trade Alerts - Newser
Risk vs reward if holding onto Akero Therapeutics Inc.2025 Institutional Moves & Breakout Confirmation Alerts - Newser
Akero Therapeutics Stock Doubles on Liver Disease Drug Trial Results - MSN
Alkeon Capital Management LLC Sells 210,334 Shares of Akero Therapeutics, Inc. $AKRO - MarketBeat
ADAR1 Capital Management LLC Raises Holdings in Akero Therapeutics, Inc. $AKRO - MarketBeat
Redmile Group LLC Sells 295,932 Shares of Akero Therapeutics, Inc. $AKRO - MarketBeat
Akero Therapeutics stock initiated with Buy rating at H.C. Wainwright - Investing.com
Baker BROS. Advisors LP Trims Holdings in Akero Therapeutics, Inc. $AKRO - MarketBeat
Should you wait for a breakout in Akero Therapeutics Inc.Market Volume Report & Advanced Swing Trade Entry Plans - Newser
Best data tools to analyze Akero Therapeutics Inc. stockMarket Volume Report & Advanced Swing Trade Entry Plans - Newser
Will Akero Therapeutics Inc. continue its uptrendJuly 2025 Earnings & Verified High Yield Trade Plans - Newser
Chart based exit strategy for Akero Therapeutics Inc.July 2025 Short Interest & AI Based Buy and Sell Signals - Newser
Earnings Miss: Can Akero Therapeutics Inc. disrupt its industryTrade Risk Summary & Risk Controlled Stock Alerts - خودرو بانک
How to build a dashboard for Akero Therapeutics Inc. stockWeekly Trade Report & Precise Swing Trade Entry Alerts - Newser
16,473 Shares in Akero Therapeutics, Inc. $AKRO Acquired by FORA Capital LLC - MarketBeat
Historical volatility pattern of Akero Therapeutics Inc. visualized2025 Trade Ideas & Weekly Top Performers Watchlists - Newser
Can trapped investors hope for a rebound in Akero Therapeutics Inc.July 2025 Intraday Action & Accurate Trade Setup Notifications - Newser
Akero Therapeutics, Inc. $AKRO Position Trimmed by Tema Etfs LLC - MarketBeat
How to escape a deep drawdown in Akero Therapeutics Inc.Treasury Yields & Real-Time Stock Entry Alerts - Newser
Akero Therapeutics Inc. stock daily chart insightsBear Alert & Real-Time Volume Surge Alerts - Newser
Published on: 2025-09-03 20:48:57 - beatles.ru
Akero Therapeutics Inc. recovery potential after sell off2025 Fundamental Recap & Weekly High Return Forecasts - Newser
Using flow based indicators on Akero Therapeutics Inc.2025 Market Overview & Smart Allocation Stock Reports - Newser
Intraday pattern recognizer results for Akero Therapeutics Inc.Rate Hike & AI Enhanced Trading Alerts - Newser
Walleye Capital LLC Decreases Stock Holdings in Akero Therapeutics, Inc. $AKRO - MarketBeat
Chart overlay techniques for tracking Akero Therapeutics Inc.Quarterly Profit Summary & Free Weekly Chart Analysis and Trade Guides - Newser
Market reaction to Akero Therapeutics Inc.’s recent newsEarnings Overview Summary & Weekly Breakout Stock Alerts - Newser
What MACD and RSI say about Akero Therapeutics Inc.Weekly Trade Summary & Growth Oriented Trading Recommendations - Newser
Akero Therapeutics Inc (AKRO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):